BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 35430635)

  • 21. Meta-analysis of high power short duration in atrial fibrillation ablation - a superior efficient ablation strategy.
    Xu M; Yang Y; Zhang D; Jiang W
    Acta Cardiol; 2022 Feb; 77(1):14-32. PubMed ID: 34218737
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy and safety of high-power short duration atrial fibrillation ablation in elderly patients.
    Müller J; Nentwich K; Berkovitz A; Ene E; Sonne K; Chakarov I; Barth S; Waechter C; Lüsebrink U; Behnes M; Akin I; Deneke T
    J Cardiovasc Electrophysiol; 2022 Jul; 33(7):1425-1434. PubMed ID: 35441414
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High-power short duration and low-power long duration in atrial fibrillation ablation: A meta-analysis.
    Kewcharoen J; Techorueangwiwat C; Kanitsoraphan C; Leesutipornchai T; Akoum N; Bunch TJ; Navaravong L
    J Cardiovasc Electrophysiol; 2021 Jan; 32(1):71-82. PubMed ID: 33155303
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Safety aspects of very high power very short duration atrial fibrillation ablation using a modified radiofrequency RF-generator: Single-center experience.
    Mueller J; Halbfass P; Sonne K; Nentwich K; Ene E; Berkovitz A; Lehmkuhl L; Barth S; Simu GR; Waechter C; Behnes M; Deneke T
    J Cardiovasc Electrophysiol; 2022 May; 33(5):920-927. PubMed ID: 35233883
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of High-Power and Very High-Power Short-Duration Radiofrequency Ablation on Procedure Characteristics and First-Pass Isolation During Pulmonary Vein Isolation.
    Salló Z; Perge P; Balogi B; Orbán G; Piros K; Herczeg S; Nagy KV; Osztheimer I; Ábrahám P; Merkely B; Gellér L; Szegedi N
    Front Cardiovasc Med; 2022; 9():935705. PubMed ID: 35872909
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Meta-analysis comparing outcomes of high-power short-duration and low-power long-duration radiofrequency ablation for atrial fibrillation.
    Khanra D; Hamid A; Deshpande S; Mukherjee A; Petkar S; Saeed M; Basu-Ray I
    Anatol J Cardiol; 2022 Jan; 26(1):2-14. PubMed ID: 35191380
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Safety and outcome of very high-power short-duration ablation using 70 W for pulmonary vein isolation in patients with paroxysmal atrial fibrillation.
    Kottmaier M; Popa M; Bourier F; Reents T; Cifuentes J; Semmler V; Telishevska M; Otgonbayar U; Koch-Büttner K; Lennerz C; Bartkowiak M; Kornmayer M; Rousseva E; Brkic A; Grebmer C; Kolb C; Hessling G; Deisenhofer I
    Europace; 2020 Mar; 22(3):388-393. PubMed ID: 31872249
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High-Power Radiofrequency Catheter Ablation of Atrial Fibrillation: Using Late Gadolinium Enhancement Magnetic Resonance Imaging as a Novel Index of Esophageal Injury.
    Baher A; Kheirkhahan M; Rechenmacher SJ; Marashly Q; Kholmovski EG; Siebermair J; Acharya M; Aljuaid M; Morris AK; Kaur G; Han FT; Wilson BD; Steinberg BA; Marrouche NF; Chelu MG
    JACC Clin Electrophysiol; 2018 Dec; 4(12):1583-1594. PubMed ID: 30573123
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Radiofrequency ablation of atrial fibrillation-50 W or 90 W?
    Mueller J; Nentwich K; Ene E; Berkovitz A; Sonne K; Chakarov I; Barth S; Waechter C; Behnes M; Akin I; Halbfass P; Deneke T
    J Cardiovasc Electrophysiol; 2022 Dec; 33(12):2504-2513. PubMed ID: 36124396
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Incidence of ablation-induced esophageal injury associated with high-power short duration temperature-controlled pulmonary vein isolation using a specialized open-irrigated ablation catheter: A retrospective single-center study.
    Piringer R; Deneke T; Foldyna B; Sonne K; Nentwich K; Ene E; Barth S; Lüsebrink U; Berkovitz A; Halbfass P
    J Cardiovasc Electrophysiol; 2021 Mar; 32(3):695-703. PubMed ID: 33442930
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of high-power short-duration atrial fibrillation ablation technique on the incidence of silent cerebral embolism: a prospective randomized controlled study.
    Chen WJ; Gan CX; Cai YW; Liu YY; Xiao PL; Zou LL; Xiong QS; Qin F; Tao XX; Li R; Du HA; Liu ZZ; Yin YH; Ling ZY
    BMC Med; 2023 Nov; 21(1):461. PubMed ID: 37996906
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Acute oesophageal safety of high-power short duration with 50 W for atrial fibrillation ablation.
    Müller J; Berkovitz A; Halbfass P; Nentwich K; Ene E; Sonne K; Simu G; Chakarov I; Barth S; Waechter C; Behnes M; Akin I; Deneke T
    Europace; 2022 Jul; 24(6):928-937. PubMed ID: 35134155
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reconnection patterns after CLOSE-guided 50 W high-power-short-duration circumferential pulmonary vein isolation and substrate modification-PV reconnection might no longer be an issue.
    Francke A; Scharfe F; Schoen S; Wunderlich C; Christoph M
    J Cardiovasc Electrophysiol; 2022 Jun; 33(6):1136-1145. PubMed ID: 35118734
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High-power, short-duration ablation in the coronary sinus: clinical cases and preliminary observations on swine hearts.
    Ma C; Yin X; Xia Y; Sun J; Dai S; Gao L; Xiao X; Sun Y; Zhang R; Dong Y; Wang Z; Yu X
    J Interv Card Electrophysiol; 2022 Mar; 63(2):311-321. PubMed ID: 33856622
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Colchicine usage for prevention of post atrial fibrillation ablation pericarditis in patients undergoing high-power short-duration ablation.
    Iqbal AM; Li KY; Gautam S
    J Cardiovasc Electrophysiol; 2023 Jun; 34(6):1370-1376. PubMed ID: 37232420
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison between High-Power Short-Duration and Conventional Ablation Strategy in Atrial Fibrillation: An Updated Meta-Analysis.
    Li M; Ma Y; Lin Q; Huang Y; Liu Y; Tu T; Liu Q
    Cardiovasc Ther; 2022; 2022():1065077. PubMed ID: 35975140
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Atrial fibrillation ablation workflow optimization facilitated by high-power short-duration ablation and high-resolution mapping.
    Fink T; Sciacca V; Nischik F; Bergau L; Guckel D; El Hamriti M; Khalaph M; Braun M; Winnik S; Didenko M; Imnadze G; Sommer P; Sohns C
    Europace; 2024 Mar; 26(3):. PubMed ID: 38516791
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Myocardial injury and inflammation following pulsed-field ablation and very high-power short-duration ablation for atrial fibrillation.
    Popa MA; Bahlke F; Kottmaier M; Foerschner L; Bourier F; Lengauer S; Telishevska M; Krafft H; Englert F; Reents T; Lennerz C; Caluori G; Jaïs P; Hessling G; Deisenhofer I
    J Cardiovasc Electrophysiol; 2024 Feb; 35(2):317-327. PubMed ID: 38105426
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Predictors of Long-term Success After Concomitant Surgical Ablation for Atrial Fibrillation.
    Pecha S; Ghandili S; Hakmi S; Willems S; Reichenspurner H; Wagner FM
    Semin Thorac Cardiovasc Surg; 2017 Autumn; 29(3):294-298. PubMed ID: 28964598
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term follow-up of patients with paroxysmal atrial fibrillation and severe left atrial scarring: comparison between pulmonary vein antrum isolation only or pulmonary vein isolation combined with either scar homogenization or trigger ablation.
    Mohanty S; Mohanty P; Di Biase L; Trivedi C; Morris EH; Gianni C; Santangeli P; Bai R; Sanchez JE; Hranitzky P; Gallinghouse GJ; Al-Ahmad A; Horton RP; Hongo R; Beheiry S; Elayi CS; Lakkireddy D; Madhu Reddy Y; Viles Gonzalez JF; Burkhardt JD; Natale A
    Europace; 2017 Nov; 19(11):1790-1797. PubMed ID: 28039211
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.